New initiatives include niche and value brand entries, as well as initial production of new form factors
MONCTON, New Brunswick, April 23, 2020–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide an update related to the Company’s current and anticipated releases of new adult use recreational cannabis products.
In order to ensure the Company’s offerings are aligned with anticipated customer preferences, Organigram conducts ongoing consumer research and leverages detailed analysis of consumer purchasing behaviours across Canada. As a result, Organigram’s strategic and product development teams have been able to develop a diverse, creative and high-quality portfolio of cannabis products that are designed to reflect Canadians’ appreciation for value, unique experiences and new form factors.
At Organigram, we remain wholly committed to exploring new and innovative cannabis experiences. Evolving consumer preferences and expectations inform our strategic approach to product development in real time, every day.
Greg Engel, CEO, Organigram
We are proud of our team’s ability to understand the market as it rapidly changes and respond in kind with novel, value-driven products.
TRAILER PARK BUDS
Through a new licensing agreement with Trailer Park Boys Incorporated, Organigram is pleased to introduce Trailer Park Buds (TPB), a quality adult recreational use consumer brand intended to compete in the fast-growing high volume, value-focused segment. TPB will initially be available as 28g of dried flower and will include two cultivars: Itodaso Indica and Two Birds Sativa.
Organigram has obtained listings for TPB in a number of provinces with plans to start shipping this month.
The Company is excited to announce that following an analysis of production and packaging impacts relative to COVID-19, it expects ANKR Organics to launch in Fiscal Q3 2020.
As one of Canada’s original legal cultivators of organic cannabis, Organigram has invested several years of research into organic cannabis cultivation. The Company expects to launch its ANKR Organics product line in 3.5 g format in select markets.
PAX ERA PODS
The Company has filled its first volumes of Edison Cannabis Company-branded pods specifically for the PAX Era platform, premium oil vaporizers created by PAX Labs, Inc. (“PAX”), destined for markets across Canada.
Organigram is one of PAX’s six Canadian commercial partners. PAX describes itself as a leader in the design and development of premium app-controlled vaporization technologies and devices, for cannabis flower and concentrates. Internationally, PAX has sold more than one million Era devices for oil concentrates and over one million devices in the flower vaporizer category.
Organigram will produce and fill Edison Cannabis Company-branded PAX Era pods onsite at the Company’s Moncton facility. Organigram will offer these pods to all provincial partners where regulations permit in an effort to achieve optimal distribution.
“Our collaboration with PAX reflects our ongoing commitment to innovative products, novel product forms and new cannabis experiences,” says Engel. “This product rounds out Organigram’s vape offering, which we consider to be one of the best vape portfolios in the industry with leading products in 510, ready to use and closed loop form factors.”
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.
Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Trailer Park Buds, Ankr Organics and Trailblazer. Organigram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).